A verdict has been found in the class action lawsuit filed against Cytodyne Technologies on behalf of consumers. The court has ordered the company to pay $12,536,820, the amount identified as "obtained by means of unlawful practice." The suit alleged that the companies advertisements for its ephedra-based Xenadrine RFA-1 diet products were deceptive. (May-30-03) [EMAIL LAW FIRM
If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in the form to the right to submit your complaint.